Browse treatments

…rter PFS (HR = 1.54, 95% CI 1.39-1.70, p < 0.001). In contrast, probiotics showed a supportive and positive effect on immunotherapy outcom…

…otics and probiotics appear to exert opposite associations with immunotherapy outcomes in NSCLC. These findings support the microbiota as a c…

…ective anti-tumor immunity and contributes to poor responses to immunotherapy. γδ T cells represent a distinct subset of T lymphocytes capabl…

…h several novel cancer drugs such as osimertinib, alectinib and immunotherapy are not approved for use in advanced NSCLC. While this cost asy…

…management of advanced non-small cell lung cancer, establishing immunotherapy as a cornerstone of treatment. However, the therapeutic benefit…

…ase II study by Ottenhof et al evaluated 33 patients undergoing chemoradiotherapy as primary treatment for locoregionally advanced PeCa. They rep…

…nded DNA antibody levels. Both patients responded favourably to immunotherapy. These cases add to the existing literature by describing uniqu…

…veness of patients with metastatic TNBC and brain metastases to immunotherapy. The ability of ADCs to penetrate a blood-brain barrier that is…

…and provide a rationale for combining dietary intervention with immunotherapy.…

…he patient received neoadjuvant platinum-based chemotherapy and immunotherapy without a significant radiographic response. Subsequent lobecto…

…nity, positioning this axis as a promising target for enhancing immunotherapy efficiency in malignancies, including CRC and other ICB-resista…

…Immunotherapy has transformed cancer treatment, yet its efficacy in solid tum…